Retiro De Equipo (Recall) de Device Recall Alaris

Según U.S. Food and Drug Administration, este evento ( retiro de equipo (recall) ) involucró a un dispositivo médico en United States que fue producido por CareFusion Corporation.

¿Qué es esto?

Una corrección al equipo o acción de retiro tomada por el fabricante para abordar un problema con un dispositivo médico. Los retiros (recalls) ocurren cuando un dispositivo médico está defectuoso, cuando puede poner en riesgo la salud, o cuando simultáneamente está defectuoso y puede poner en riesgo la salud.

Más información acerca de la data acá
  • Tipo de evento
    Recall
  • ID del evento
    56257
  • Clase de Riesgo del Evento
    Class 1
  • Número del evento
    Z-0006-2011
  • Fecha de inicio del evento
    2010-07-13
  • Fecha de publicación del evento
    2010-10-13
  • Estado del evento
    Terminated
  • País del evento
  • Fecha de finalización del evento
    2011-12-12
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    infusion pump and monitor - Product Code FRN
  • Causa
    Under certain wireless network conditions a communication error can occur, which freezes the pc unit screen, which may result in a delay of therapy. a delay of therapy may result in serious injury and/or death. carefusion identified this potential risk associated with the alaris pc unit model 8015 only (pc unit) manufactured between december-2008 and september-2009.
  • Acción
    CareFusion sent the customer notification letter to all customers using the affected Alaris PC Unit beginning August 24, 2010. The customer notification letter is addressed to the Directors of Nursing, Risk Management, and Biomedical Engineering. Customers will be required to confirm receipt of the notification by returning the Recall Response Card to CareFusion by postage-paid, self-addressed mail, fax or email. The recall notice informed the customers of the reason for the notice, the units affected, the potential risk, a step-by-step description of the issue and the required actions for users. The customers were also told that CareFusion will contact their facility through phone or in person within 60 days to initiate implementation of the corrective action. The corrective action will require a hardware update to all affected units. CareFusion does not require that you return your devices. In the interim, if you observe this issue, remove the device from service and contact CareFusion Recall Center immediately. Customers were also told that any adverse reactions experienced with the use of this product, and/or quality problems should also be reported to the FDA's MedWatch Program. The recall notice provided contact information for CareFusion's Recall Center, Customer Advocacy and Technical Support units.

Device

  • Modelo / Serial
  • Clasificación del producto
  • Clase de dispositivo
    2
  • ¿Implante?
    No
  • Distribución
    Nationwide and worldwide to: Canada, Netherlands, New Zealand and Singapore
  • Descripción del producto
    CareFusion Alaris PC Unit Model 8015 (formerly Medley || PC Unit): Alaris PC Units (Model 8015) with logic board part number TC10005522 manufactured and serviced between December || 20, 2008 and May 6, 2009; and Alaris PC Units (with logic board part number TC10005572 manufactured and serviced between May 7, 2009 and September 8, 2009. For use with Alaris infusion and monitoring systems.
  • Manufacturer

Manufacturer

  • Dirección del fabricante
    CareFusion Corporation, 10020 Pacific Mesa Blvd, San Diego CA 92121
  • Empresa matriz del fabricante (2017)
  • Source
    USFDA